| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 586 | 7.738 | 19.980 | 19.203 | 21.726 | 39.232 | 39.354 | 52.494 | 59.102 |
| Total Income - EUR | - | 586 | 7.738 | 19.980 | 19.203 | 21.726 | 39.232 | 39.354 | 52.494 | 59.102 |
| Total Expenses - EUR | - | 90 | 7 | 14.348 | 1.743 | 5.852 | 0 | 0 | 30.474 | 48.050 |
| Gross Profit/Loss - EUR | - | 495 | 7.732 | 5.631 | 17.459 | 15.875 | 39.232 | 39.354 | 22.021 | 11.052 |
| Net Profit/Loss - EUR | - | 478 | 7.500 | 5.031 | 16.888 | 15.170 | 39.232 | 39.354 | 21.548 | 9.314 |
| Employees | - | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Novimarmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 7.683 | 19.175 | 31.950 | 31.242 | 31.339 | 45.882 | 42.957 |
| Current Assets | - | 611 | 8.274 | 5.577 | 11.314 | 14.865 | 39.611 | 39.734 | 19.326 | 13.825 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 101 |
| Cash | - | 611 | 8.274 | 5.577 | 11.314 | 14.857 | 39.611 | 0 | 19.326 | 13.724 |
| Shareholders Funds | - | 522 | 8.013 | 12.897 | 29.535 | 44.145 | 67.565 | 67.774 | 63.847 | 42.430 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 89 | 261 | 362 | 954 | 2.670 | 3.288 | 3.299 | 1.361 | 14.352 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Novimarmed Srl